Profil
Vincent Milhau is currently a Director at Chemoxy International Ltd., Novacyl, Inc., Seqens Group Holding SAS, Seqens UK Ltd., Jiangsu Puyuan Chemical Co. Ltd., Crossco (1255) Ltd., and Seqens Holding, Inc. He is also a Member-Supervisory Board at Taixing Yangzi Pharm Chemical Co. Ltd. and Novacyl Wuxi Pharmaceutical Co. Ltd. In the past, he was the Chairman at CU Holdco GmbH, Director at PCAS SA, and Director at Polycarbon Industries, Inc. He completed his undergraduate degree at Emlyon Business School.
Additionally, he was the Chief Financial Officer at Seqens SAS from 2016 to an unknown date.
Postes actifs de Vincent Milhau
| Sociétés | Poste | Début |
|---|---|---|
Seqens UK Ltd.
Seqens UK Ltd. MiscellaneousMiscellaneous Functions as an investment holding company | Directeur/Membre du Conseil | 28/06/2017 |
Seqens SAS
Seqens SAS Chemicals: SpecialtyProcess Industries Manufactures vegetal active ingredients for cosmetics | Directeur Financier/CFO | 01/07/2016 |
Taixing Yangzi Pharm Chemical Co. Ltd.
Taixing Yangzi Pharm Chemical Co. Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and distributes medical products | Directeur/Membre du Conseil | - |
Jiangsu Puyuan Chemical Co. Ltd. | Directeur/Membre du Conseil | - |
Novacyl Wuxi Pharmaceutical Co. Ltd. | Directeur/Membre du Conseil | - |
Novacyl, Inc.
Novacyl, Inc. Pharmaceuticals: MajorHealth Technology Manufactures salicylic acid, its derivatives and aspirin | Directeur/Membre du Conseil | - |
Seqens Group Holding SAS
Seqens Group Holding SAS Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Membre du Conseil | - |
Seqens Holding, Inc. | Directeur/Membre du Conseil | - |
Chemoxy International Ltd.
Chemoxy International Ltd. Chemicals: SpecialtyProcess Industries Manufactures and processes chemicals | Directeur/Membre du Conseil | - |
| ░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Vincent Milhau
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░ ░░░░░░ ░░░░ | ░░░░░░░░░░ | - |
Formation de Vincent Milhau
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
PCAS SA
PCAS SA Pharmaceuticals: OtherHealth Technology Manufactures and sells pharmaceutical intermediaries and chemicals | Health Technology |
Chemoxy International Ltd.
Chemoxy International Ltd. Chemicals: SpecialtyProcess Industries Manufactures and processes chemicals | Process Industries |
Polycarbon Industries, Inc.
Polycarbon Industries, Inc. Chemicals: SpecialtyProcess Industries Manufactures active pharmaceutical ingredients | Process Industries |
Seqens SAS
Seqens SAS Chemicals: SpecialtyProcess Industries Manufactures vegetal active ingredients for cosmetics | Process Industries |
Taixing Yangzi Pharm Chemical Co. Ltd.
Taixing Yangzi Pharm Chemical Co. Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and distributes medical products | Health Technology |
Novacyl, Inc.
Novacyl, Inc. Pharmaceuticals: MajorHealth Technology Manufactures salicylic acid, its derivatives and aspirin | Health Technology |
Seqens Group Holding SAS
Seqens Group Holding SAS Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Emlyon Business School
Emlyon Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seqens UK Ltd.
Seqens UK Ltd. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Novacyl Wuxi Pharmaceutical Co. Ltd. | |
Jiangsu Puyuan Chemical Co. Ltd. | |
CU Holdco GmbH
CU Holdco GmbH Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Crossco (1255) Ltd.
Crossco (1255) Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Seqens Holding, Inc. |
















